Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating the Efficacy and Safety of Neonatal Chyme Reinfusion Therapy: A Feasibility Study using a Novel Medical Device

View ORCID ProfileE. Ludlow, T. Harrington, R. Davidson, J. Davidson, K. Aikins, G. O’Grady, I. Bissett
doi: https://doi.org/10.1101/2024.05.08.24306960
E. Ludlow
1Te Whatu Ora Counties Manukau
2Department of Surgery, The University of Auckland
3The Insides Company
MNur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. Ludlow
T. Harrington
3The Insides Company
4Te Whatu Ora Te Toka Tumai Auckland
BScN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Davidson
3The Insides Company
BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Davidson
3The Insides Company
PhD BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Aikins
4Te Whatu Ora Te Toka Tumai Auckland
FRACS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. O’Grady
2Department of Surgery, The University of Auckland
3The Insides Company
PhD, FRACS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Bissett
2Department of Surgery, The University of Auckland
3The Insides Company
ONZM, MD, FRACS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: i.bissett{at}auckland.ac.nz
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Neonatal and pediatric intestinal failure related to enterostomy is an infrequent but burdensome condition associated with substantial morbidity and mortality. This study presents the development and clinical validation of a novel device to resolve these problems, by formalizing a safe and efficient enterostomy chyme reinfusion technique.

Methods A novel neonatal chyme reinfusion device was designed and manufactured (‘The Insides Neo’, The Insides Company, New Zealand), prior to validation in a feasibility study in tertiary neonatal intensive care centres. Neonates with double enterostomy were recruited and commenced on chyme reinfusion therapy using the novel device to test safety, efficacy, tolerability, and usability within nursing workflows. Device and clinical outcomes were recorded along with nursing feedback. Registered under the ANZCTR, identifier no. ACTRN12621000835842p.

Results Ten neonates were recruited across two centres, with a median usage duration of 37.5 (range 12-84) days. Following initiation of therapy, rate of weight gain increased from mean 68.8 ± 37.4 to 197 ± 25.0 g/week (p=0.024). Of the 7/10 neonates on PN at commencement of therapy, 4/7 were able to wean and achieve enteral autonomy. All neonates tolerated the device with uniformly positive nursing feedback and minimal time to learn and incorporate the novel device into nursing workflows. There were no device-related adverse events.

Conclusions A novel device was developed and validated to be safe and effective at performing chyme reinfusion therapy in neonates. This device is anticipated to improve the clinical care and outcomes of neonatal patients with double enterostomies.

What is Known

  • Chyme reinfusion is widely accepted and is a standard of care in many centres who care for neonates with double enterostomy’s.

  • The manual application of chyme reinfusion has led to low adoption despite the many benefits.

What is New

  • A new device that automates the process of chyme reinfusion that overcomes many of the barriers outlined in the literature.

  • Uniformly positive nursing feedback that streamlines the Neonatal Intensive Care Unit (NICU) workflow.

Competing Interest Statement

E. Ludlow is an employee and shareholder in The Insides Company T. Harrington contracts to The Insides Company R. Davidson, J. Davidson, G. OGrady, and I. Bissett are Founders of The Insides Company

Clinical Trial

ACTRN12621000835842p

Funding Statement

The study was funded by a grant from Cure Kids to hire a research nurse and assist with research and development costs associated with The Insides Neo. Devices were supplied by The Insides Company.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

New Zealand Health and Disability Committees The Northern B Health and Disability Ethics Committee approved the study 16/Aug/2021 Ethics ref: 21/NTB/150 Study title: Neonate stoma refeeding device feasibility study

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • This version of the manuscript has been revised and the Discussion and Methods have been updated with more clarification

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    NEC
    Necrotising enterocolitis
    CRT
    Chyme Reinfusion Therapy
    PN
    Parenteral Nutrition
    EN
    Enteral Nutrition
    NICU
    Neonatal Intensive Care Unit
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted August 15, 2024.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Evaluating the Efficacy and Safety of Neonatal Chyme Reinfusion Therapy: A Feasibility Study using a Novel Medical Device
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Evaluating the Efficacy and Safety of Neonatal Chyme Reinfusion Therapy: A Feasibility Study using a Novel Medical Device
    E. Ludlow, T. Harrington, R. Davidson, J. Davidson, K. Aikins, G. O’Grady, I. Bissett
    medRxiv 2024.05.08.24306960; doi: https://doi.org/10.1101/2024.05.08.24306960
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Evaluating the Efficacy and Safety of Neonatal Chyme Reinfusion Therapy: A Feasibility Study using a Novel Medical Device
    E. Ludlow, T. Harrington, R. Davidson, J. Davidson, K. Aikins, G. O’Grady, I. Bissett
    medRxiv 2024.05.08.24306960; doi: https://doi.org/10.1101/2024.05.08.24306960

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Nutrition
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)